Paper41209618
Neutrophil extracellular traps predict poor response and prognosis in non-small cell lung cancer immunotherapy.
Lv J and 6 others. Ther Adv Med Oncol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Neutrophil extracellular traps predict poor response and prognosis in non-small cell lung cancer immunotherapy. Papers, record 41209618. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41209618
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Neutrophil extracellular traps predict poor response and prognosis in non-small cell lung cancer immunotherapy.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References44
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32843638 | The updated landscape of tumor microenvironment and drug repurposing. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32843638 | PubMed |
| 2 | 36827980 | NETworking with cancer: The bidirectional interplay between cancer and neutrophil extracellular traps. | Cancer Cell | 2023 | https://conductscience.org/library/papers/36827980 | PubMed |
| 3 | 35998825 | Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35998825 | PubMed |
| 4 | 27506216 | The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas. | Cell Tissue Res | 2016 | https://conductscience.org/library/papers/27506216 | PubMed |
| 5 | 32289253 | CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity. | Immunity | 2020 | https://conductscience.org/library/papers/32289253 | PubMed |
| 6 | 38642131 | A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis. | Cancer Immunol Immunother | 2024 | https://conductscience.org/library/papers/38642131 | PubMed |
| 7 | 33514748 | Stromal-driven and Amyloid β-dependent induction of neutrophil extracellular traps modulates tumor growth. | Nat Commun | 2021 | https://conductscience.org/library/papers/33514748 | PubMed |
| 8 | 17979848 | 'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation. | Immunol Rev | 2007 | https://conductscience.org/library/papers/17979848 | PubMed |
| 9 | 40382454 | Prognostic Impact of the Pathologic Response of Patients with Hepatocellular Carcinoma After Preoperative Treatments. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40382454 | PubMed |
| 10 | 38057451 | Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations. | Nat Rev Immunol | 2024 | https://conductscience.org/library/papers/38057451 | PubMed |
| 11 | 37985191 | Management of locally advanced non-small cell lung cancer: State of the art and future directions. | Cancer Commun (Lond) | 2024 | https://conductscience.org/library/papers/37985191 | PubMed |
| 12 | 38039967 | The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer. | Immunity | 2023 | https://conductscience.org/library/papers/38039967 | PubMed |
| 13 | 1831127 | Expression of different CD8 isoforms on distinct human lymphocyte subpopulations. | Eur J Immunol | 1991 | https://conductscience.org/library/papers/1831127 | PubMed |
| 14 | 33580222 | PD-L1 as a biomarker of response to immune-checkpoint inhibitors. | Nat Rev Clin Oncol | 2021 | https://conductscience.org/library/papers/33580222 | PubMed |
| 15 | 38661680 | A combined model of serum neutrophil extracellular traps, CD8+ T cells, and tumor proportion score provides better prediction of PD-1 inhibitor efficacy in patients with NSCLC. | FEBS J | 2024 | https://conductscience.org/library/papers/38661680 | PubMed |
| 16 | 33811125 | Therapeutic Targeting of the Tumor Microenvironment. | Cancer Discov | 2021 | https://conductscience.org/library/papers/33811125 | PubMed |
| 17 | 27151975 | Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. | Genes Dev | 2016 | https://conductscience.org/library/papers/27151975 | PubMed |
| 18 | 38381538 | DNA of Neutrophil Extracellular Traps Binds TMCO6 to Impair CD8+ T-cell Immunity in Hepatocellular Carcinoma. | Cancer Res | 2024 | https://conductscience.org/library/papers/38381538 | PubMed |
| 19 | 30898862 | Neutrophils and NETs in modulating acute and chronic inflammation. | Blood | 2019 | https://conductscience.org/library/papers/30898862 | PubMed |
| 20 | 29507342 | Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells. | Nat Commun | 2018 | https://conductscience.org/library/papers/29507342 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974100 | Cancer-associated fibroblasts and innate immune cells: orchestrators of the immunosuppressive tumor microenvironment. | Front Immunol | 2026 | https://conductscience.org/library/papers/42974100 | PubMed |
| 42930547 | Neutrophils and Neutrophil Extracellular Traps in Cancer and Cardio-Oncology: Molecular Mechanisms, Therapeutic Targeting, and Clinical Perspectives. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42930547 | PubMed |
| 42859163 | Metabolic reprogramming in cancer-associated fibroblasts: orchestrating the tumor immune microenvironment and response to immune checkpoint blockade. | Exp Hematol Oncol | 2026 | https://conductscience.org/library/papers/42859163 | PubMed |
| 42707690 | Immunosuppressive cells as barriers to cancer therapy: mechanisms and emerging solutions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42707690 | PubMed |
| 42286174 | Prognostic significance of intratumoral neutrophil extracellular traps in pulmonary pleomorphic carcinoma: comparison with adenocarcinoma. | BJC Rep | 2026 | https://conductscience.org/library/papers/42286174 | PubMed |
| 42277951 | Roles of neutrophil extracellular traps in cancer immunotherapy resistance and therapeutic targeting. | Biomark Res | 2026 | https://conductscience.org/library/papers/42277951 | PubMed |
| 42233035 | Tumor immune microenvironment in non-small cell lung cancer progression. | Front Immunol | 2026 | https://conductscience.org/library/papers/42233035 | PubMed |
| 41897336 | The Neutrophil-NET Axis in Immune Checkpoint Inhibitor Resistance in Non-Small Cell Lung Cancer: Roles, Biomarkers and Therapeutic Opportunities. | Biomolecules | 2026 | https://conductscience.org/library/papers/41897336 | PubMed |
| 41516132 | Intratumoral Microbiota in Lung Cancer: Emerging Roles in TME Modulation and Immunotherapy Response. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516132 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41209618
GET https://conductscience.org/api/papers/v1/41209618/references?page=2